Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury

Pain

Volumn 145, Issue 3, 2009, Pages 294-303

  Puente, Beatriz de la ^a   Nadal, Xavier ^b   Portillo Salido, Enrique ^a   Sánchez Arroyos, Ricard ^a   Ovalle, Sergio ^a   Palacios, Gabriel ^a   Muro, Asunción ^a   Romero, Luz ^a   Entrena, José Manuel ^c   Baeyens, José Manuel ^c   López García, José Antonio ^d   Maldonado, Rafael ^b   Zamanillo, Daniel ^a   Vela, José Miguel ^a  

^a ESTEVE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Allodynia; Central sensitization; ERK; Hyperalgesia; Neuropathic pain; Sigma 1 receptor; Spinal cord; Wind up

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SIGMA 1 OPIATE RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GENE; KNOCKOUT MOUSE; MALE; MOUSE; NERVE LIGATION; NERVE POTENTIAL; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCIATIC NERVE; SENSITIVITY ANALYSIS; SENSITIZATION; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BIOPHYSICS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HYPERALGESIA; MALE; MICE; MICE, KNOCKOUT; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; REACTION TIME; RECEPTORS, SIGMA; SCIATIC NEUROPATHY; SPINAL CORD;

EID: 69649104522     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.05.013     Document Type: Article

References (74)

1. Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., and Maurice T. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97 (2000) 155-170
2. Aydar E., Palmer C.P., Klyachko V.A., and Jackson M.B. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34 (2002) 399-410
3. Baron R. Mechanisms of disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol 2 (2006) 95-106
4. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
5. Bergeron R., de Montigny C., and Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 16 (1996) 1193-1202
6. Brenner G.J., Ji R.R., Shaffer S., and Woolf C.J. Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur J Neurosci 20 (2004) 375-384
7. Cendán C.M., Pujalte J.M., Portillo-Salido E., and Baeyens J.M. Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacology (Berl) 182 (2005) 485-493
8. Cendán C.M., Pujalte J.M., Portillo-Salido E., Montoliu L., and Baeyens J.M. Formalin-induced pain is reduced in sigma(1) receptor knockout mice. Eur J Pharmacol 511 (2005) 73-74
9. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
10. Chien C.C., and Pasternak G.W. Selective antagonism of opioid analgesia by a sigma system. J Pharmacol Exp Ther 271 (1994) 1583-1590
11. Chien C.C., and Pasternak G.W. Sigma antagonists potentiate opioid analgesia in rats. Neurosci Lett 190 (1995) 137-139
12. Ciruela A., Dixon A.K., Bramwell S., Gonzalez M.I., Pinnock R.D., and Lee K. Identification of MEK1 as a novel target for the treatment of neuropathic pain. Br J Pharmacol 138 (2003) 751-756
13. Cobos E.J., Baeyens J.M., and Del Pozo E. Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain. Synapse 55 (2005) 192-195
14. Cobos E.J., del Pozo E., and Baeyens J.M. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J Neurochem 102 (2007) 812-825
15. Cobos E.J., Entrena J.M., Nieto F.R., Cendán C.M., and Del Pozo E. Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol 6 (2008) 344-366
16. Coderre T.J. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol Neurobiol 7 (1993) 229-246 [fall-winter]
17. Dickenson A.H., and Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 26 (1987) 1235-1238
18. Entrena J.M., Cobos E.J., Nieto F.R., Cendán C.M., Gris G., Del Pozo E., Zamanillo D., and Baeyens J.M. Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain 143 (2009) 252-261
19. Fang L., Wu J., Lin Q., and Willis W.D. Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensitization. J Neurosci 22 (2002) 4196-4204
20. Fontanilla D., Johannessen M., Hajipour A.R., Cozzi N.V., Jackson M.B., and Ruoho A.E. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323 (2009) 934-937
21. Fukui T., Dai Y., Iwata K., Kamo H., Yamanaka H., Obata K., Kobayashi K., Wang S., Cui X., Yoshiya S., and Noguchi K. Frequency-dependent ERK phosphorylation in spinal neurons by electric stimulation of the sciatic nerve and the role in electrophysiological activity. Mol Pain 16 (2007) 3-18
22. Guitart X., Codony X., and Monroy X. Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl) 174 (2004) 301-319
23. Hanner M., Moebius F.F., Flandorfer A., Knaus H.G., Striessnig J., Kempner E., and Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93 (1996) 8072-8077
24. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
25. ++ mobilization by N-methyl-d-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther 275 (1995) 207-214
26. Hayashi T., Maurice T., and Su T.P. Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther 293 (2000) 788-798
27. Hayashi T., and Su T.P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci USA 98 (2001) 491-496
28. Hayashi T., and Su T.P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131 (2007) 596-610
29. Hayashi T., and Su T.P. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 306 (2003) 718-725
30. Hayashi T., and Su T.P. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci 77 (2005) 1612-1624
31. Herrero J.F., Laird J.M., and López-García J.A. Wind-up of spinal cord neurones and pain sensation: much ado about something?. Prog Neurobiol 61 (2000) 169-203
32. Hua X.Y., Chen P., and Yaksh T.L. Inhibition of spinal protein kinase C reduces nerve injury-induced tactile allodynia in neuropathic rats. Neurosci Lett 276 (1999) 99-102
33. Igwe O.J., and Ning L. Regulation of the second-messenger systems in the rat spinal cord during prolonged peripheral inflammation. Pain 58 (1994) 63-75
34. Ji R.R., Baba H., Brenner G.J., and Woolf C.J. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 2 (1999) 1114-1119
35. Ji R.R., and Woolf C.J. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8 (2001) 1-10
36. Kawasaki Y., Kohno T., Zhuang Z.Y., Brenner G.J., Wang H., Van Der Meer C., Befort K., Woolf C.J., and Ji R.R. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 24 (2004) 8310-8321
37. Kim H.W., Kwon Y.B., Roh D.H., Yoon S.Y., Han H.J., Kim K.W., Beitz A.J., and Lee J.H. Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice. Br J Pharmacol 148 (2006) 490-498
38. Kim H.W., Roh D.H., Yoon S.Y., Seo H.S., Kwon Y.B., Han H.J., Kim K.W., Beitz A.J., and Lee J.H. Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br J Pharmacol 154 (2008) 1125-1134
39. King M., Pan Y.X., Mei J., Chang A., Xu J., and Pasternak G.W. Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor. Eur J Pharmacol 331 (1997) R5-R6
40. Kitaichi K., Chabot J.G., Moebius F.F., Flandorfer A., Glossmann H., and Quirion R. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat 20 (2000) 375-387
41. Langa F., Codony X., Tovar V., Lavado A., Giménez E., Cozar P., Cantero M., Dordal A., Hernández E., Pérez R., Monroy X., Zamanillo D., Guitart X., and Montoliu L. Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. Eur J Neurosci 18 (2003) 2188-2196
42. Ma W., and Quirion R. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin Ther Targets 9 (2005) 699-713
43. Malmberg A.B., and Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 76 (1998) 215-222
44. Martina M., Turcotte M.E., Halman S., and Bergeron R. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 578 (2007) 143-157
45. Martinez-Gomez J., and Lopez-Garcia J.A. Simultaneous assessment of the effects of L-type current modulators on sensory and motor pathways of the mouse spinal cord in vitro. Neuropharmacology 53 (2007) 464-471
46. Martin-Fardon R., Maurice T., Aujla H., Bowen W.D., and Weiss F. Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology 32 (2007) 1967-1973
47. Maurice T. Neurosteroids and sigma1 receptors, biochemical and behavioral relevance. Pharmacopsychiatry 37 (2004) S171-S182
48. Mei J., and Pasternak G.W. Sigma1 receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther 300 (2002) 1070-1074
49. Meller S.T., Dykstra C.L., and Gebhart G.F. Investigations of the possible role for carbon monoxide (CO) in thermal and mechanical hyperalgesia in the rat. Neuroreport 5 (1994) 2337-2341
50. Mendell L.M. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 16 (1966) 316-332
51. Monnet F.P., Debonnel G., Junien J.L., and De Montigny C. N-methyl-d-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol 179 (1990) 441-445
52. Monnet F.P., and Maurice T. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J Pharmacol Sci 100 (2006) 93-118
53. Monnet F.P., Morin-Surun M.P., Leger J., and Combettes L. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. J Pharmacol Exp Ther 307 (2003) 705-712
54. 2+: clinical and therapeutic relevance. Biol Cell 97 (2005) 873-883
55. Morin-Surun M.P., Collin T., Denavit-Saubié M., Baulieu E.E., and Monnet F.P. Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci USA 96 (1999) 8196-8199
56. Mtchedlishvili Z., and Kapur J. A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission. Mol Pharmacol 64 (2003) 857-864
57. Nieto F.R., Entrena J.M., Cendán C.M., Pozo E.D., Vela J.M., and Baeyens J.M. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain 137 (2008) 520-531
58. Palacios G., Muro A., Vela J.M., Molina-Holgado E., Guitart X., Ovalle S., and Zamanillo D. Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system. Brain Res 961 (2003) 92-99
59. Palacios G., Muro A., Verdú E., Pumarola M., and Vela J.M. Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve. Brain Res 1007 (2004) 65-70
60. Pan Y.X., Mei J., Xu J., Wan B.L., Zuckerman A., and Pasternak G.W. Cloning and characterization of a mouse sigma1 receptor. J Neurochem 70 (1998) 2279-2285
61. Peeters M., Romieu P., Maurice T., Su T.P., Maloteaux J.M., and Hermans E. Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine. Eur J Neurosci 19 (2004) 2212-2220
62. Prasad P.D., Li H.W., Fei Y.J., Ganapathy M.E., Fujita T., Plumley L.H., Yang-Feng T.L., Leibach F.H., and Ganapathy V. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene. J Neurochem 70 (1998) 443-451
63. Roh D.H., Kim H.W., Yoon S.Y., Seo H.S., Kwon Y.B., Kim K.W., Han H.J., Beitz A.J., Na H.S., and Lee J.H. Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology 109 (2008) 879-889
64. Roh D.H., Kim H.W., Yoon S.Y., Seo H.S., Kwon Y.B., Kim K.W., Han H.J., Betz A.J., and Lee J.H. Intrathecal administration of sigma-1 receptor agonists facilitates nociception: involvement of a protein kinase C-dependent pathway. J Neurosci Res 86 (2008) 3644-3654
65. Song X.S., Cao J.L., Xu Y.B., He J.H., Zhang L.C., and Zeng Y.M. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats. Acta Pharmacol Sin 26 (2005) 789-798
66. Soriani O., Le Foll F., Galas L., Roman F., Vaudry H., and Cazin L. The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs. Am J Physiol 277 (1999) E73-E80
67. Su T.P., and Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 10 (2003) 2073-2080
68. Treede R.D., Meyer R.A., Raja S.N., and Campbell J.N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38 (1992) 397-421
69. Willis W.D. Role of neurotransmitters in sensitization of pain responses. Ann NY Acad Sci 933 (2001) 142-156
70. Woolf C.J., and Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 44 (1991) 293-299
71. Xin W.J., Gong Q.J., Xu J.T., Yang H.W., Zang Y., Zhang T., Li Y.Y., and Liu X.G. Role of phosphorylation of ERK in induction and maintenance of LTP of the C-fiber evoked field potentials in spinal dorsal horn. J Neurosci Res 84 (2006) 934-943
72. Zamanillo D., Andreu F., Ovalle S., Pérez M.P., Romero G., Farré A.J., and Guitart X. Up-regulation of sigma(1) receptor mRNA in rat brain by a putative atypical antipsychotic and sigma receptor ligand. Neurosci Lett 282 (2000) 169-172
73. Zhuang Z.Y., Gerner P., Woolf C.J., and Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114 (2005) 149-159
74. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110